Azithromycin Resistance in Shiga Toxin-Producing Escherichia coli in France between 2004 and 2020 and Detection of mef(C)- mph(G) Genes

Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0194921. doi: 10.1128/AAC.01949-21. Epub 2021 Dec 6.

Abstract

We described and characterized Shiga-toxin-producing Escherichia coli (STEC) strains with high levels of resistance to azithromycin isolated in France between 2004 and 2020. Nine of 1,715 (0.52%) STEC strains were resistant to azithromycin, with an increase since 2017. One isolate carried a plasmid-borne mef(C)-mph(G) gene combination, described here for the first time for E. coli. Azithromycin resistance, although rare, needs consideration, as this treatment may be useful in cases of STEC infection.

Keywords: EHEC; azithromycin resistance; fosfomycin; macrolide resistance; macrolides; mef(C)-mph(G); mph(A); mph(B); phosphorylases; rifaximin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azithromycin / pharmacology
  • Escherichia coli Infections* / drug therapy
  • Escherichia coli Proteins* / genetics
  • Humans
  • Plasmids / genetics
  • Shiga-Toxigenic Escherichia coli* / genetics

Substances

  • Escherichia coli Proteins
  • Azithromycin